Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference4%

- Check29 days agoChange DetectedRelease updated to v3.1.0 and removal of several drug-safety topic sections (e.g., Drug Safety, Counterfeit Drugs, Substandard Drugs, Pharmaceutical Preparations) along with an older version tag (v3.0.2).SummaryDifference0.5%

- Check43 days agoChange DetectedThe page is updated to revision v3.0.2 from v3.0.1, and the 'Back to Top' element was removed; no substantive content changes are indicated.SummaryDifference0.3%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%

- Check57 days agoChange DetectedThe web page has been updated to include a new facility name and location details, specifically highlighting St. Louis, Missouri, and relevant publications related to drug safety and post-COVID conditions. Additionally, the revision number has been updated to v3.0.0.SummaryDifference7%

- Check72 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.